IRIS
ALTAMURA, CONCETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.292
EU - Europa 425
AS - Asia 112
Totale 1.829
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.291
DE - Germania 113
SE - Svezia 103
IT - Italia 92
CN - Cina 75
RU - Federazione Russa 42
GB - Regno Unito 32
SG - Singapore 16
FR - Francia 14
FI - Finlandia 13
VN - Vietnam 10
IN - India 6
UA - Ucraina 5
BE - Belgio 4
TR - Turchia 3
IE - Irlanda 2
NL - Olanda 2
AT - Austria 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
HU - Ungheria 1
ID - Indonesia 1
PH - Filippine 1
Totale 1.829
Salva come PNG Salva come JPEG
Città #
Fairfield 217
Ashburn 141
Chandler 133
Houston 111
Woodbridge 107
Nyköping 86
Cambridge 73
Wilmington 60
Ann Arbor 58
Seattle 58
Bari 37
Beijing 23
Roxbury 23
Lawrence 21
Inglewood 20
New York 20
Des Moines 17
Jacksonville 17
San Diego 15
Nanjing 14
Singapore 12
Dong Ket 10
Paris 9
Washington 8
Los Angeles 7
Princeton 7
Montignoso 6
Pune 6
Brooklyn 5
Helsinki 5
Wuhan 5
Dearborn 4
Mottola 4
Nanchang 4
Guangzhou 3
Shenyang 3
Boardman 2
Brussels 2
Chicago 2
Dublin 2
Esslingen am Neckar 2
Florence 2
Hebei 2
Hohenstein-Ernstthal 2
Jiaxing 2
London 2
Magliano Alpi 2
Milan 2
Münster 2
Norwalk 2
Perugia 2
Redwood City 2
Rome 2
San Mateo 2
Shanghai 2
Taranto 2
Tianjin 2
Triggiano 2
Vinovo 2
Waanrode 2
Acquaviva delle Fonti 1
Andria 1
Augusta 1
Brno 1
Castelnuovo Rangone 1
Changsha 1
Denver 1
Fasano 1
Fort Worth 1
Giresun 1
Gravina In Puglia 1
Jinan 1
Krasnoyarsk 1
Kunming 1
Leawood 1
Lianyun 1
Makati 1
Marseille 1
Martina Franca 1
Miami 1
Modugno 1
Monmouth Junction 1
Monte San Giovanni Campano 1
Nettuno 1
New Bedfont 1
Padova 1
Prescot 1
Reston 1
San Francisco 1
San José 1
Sannicandro di Bari 1
Settingiano 1
Shenzhen 1
Simi Valley 1
Tappahannock 1
Vicenza 1
Vienna 1
Wuxi 1
Yiwu 1
Totale 1.436
Salva come PNG Salva come JPEG
Nome #
Multidisciplinary study of a new ClC-1 mutation causing myotonia congenita: a paradigm to understand and treat ion channelopathies 157
ClC-1 chloride channels: state-of-the-art research and future challenges 151
Mapping ligand binding pockets in ClC-1 channels through an integrated in silico and experimental approach using anthracene-9-carboxylic acid and niflumic acid 136
Clinical, Molecular, and Functional Characterization of CLCN1 Mutations in Three Families with Recessive Myotonia Congenita 129
ClC-1 mutations in myotonia congenita patients: insights into molecular gating mechanisms and genotype-phenotype correlation 109
The analysis of myotonia congenita mutations discloses functional clusters of amino acids within CBS2 domain and C-terminal peptide of ClC-1 channel 108
Pharmacogenetics of myotonic hNav1.4 sodium channel variants situated near the fast inactivation gate 106
Coexistence of CLCN1 and SCN4A mutations in one family suffering from myotonia 105
Effects of Benzothiazolamines on Voltage-Gated Sodium Channels 95
A novel KCNA1 mutation in a patient with paroxysmal ataxia, myokymia, painful contractures and metabolic dysfunctions 95
Ion channels gene expression analysis in myotonia congenita patients carrying ClC-1 chloride channel mutations 65
Functional characterization of ClC-1 mutations from patients affected by recessive myotonia congenita presenting with different clinical phenotypes. 61
Safinamide's potential in treating nondystrophic myotonias: Inhibition of skeletal muscle voltage-gated sodium channels and skeletal muscle hyperexcitability in vitro and in vivo 60
Skeletal muscle ClC-1 chloride channels in health and diseases 56
Synthesis and Evaluation of Voltage-Gated Sodium Channel Blocking Pyrroline Derivatives Endowed with Both Antiarrhythmic and Antioxidant Activities 54
Pathomechanisms of a CLCN1 Mutation Found in a Russian Family Suffering From Becker's Myotonia 44
Bioisosteric Modification of To042: Synthesis and Evaluation of Promising Use-Dependent Inhibitors of Voltage-Gated Sodium Channels 44
Musculoskeletal Features without Ataxia Associated with a Novel de novo Mutation in KCNA1 Impairing the Voltage Sensitivity of Kv1.1 Channel 41
Natural ClC-1 mutations causing myotonia congenita reduce sensitivity to 9-AC 36
Targeted Therapies for Skeletal Muscle Ion Channelopathies: Systematic Review and Steps Towards Precision Medicine 35
Emerging roles for ion channels in ovarian cancer: Pathomechanisms and pharmacological treatment 33
Buprenorphine may be effective for treatment of paramyotonia congenita 33
null 29
Increased sarcolemma chloride conductance as one of the mechanisms of action of carbonic anhydrase inhibitors in muscle excitability disorders 29
Ion Channel Gene Mutations Causing Skeletal Muscle Disorders: Pathomechanisms and Opportunities for Therapy 28
Privileged scaffold-based design to identify a novel drug-like 5-HT7 receptor-preferring agonist to target Fragile X syndrome 25
Ion Channel Involvement in Tumor Drug Resistance 21
Chaperone activity of niflumic acid on ClC-1 chloride channel mutants causing myotonia congenita 19
Anti-Angiogenic Activity of Drugs in Multiple Myeloma 12
Immersive and Non-Immersive Virtual Reality for Pain and Anxiety Management in Pediatric Patients with Hematological or Solid Cancer: A Systematic Review 11
Drug repurposing in skeletal muscle ion channelopathies 10
Ion Channels in Multiple Myeloma: Pathogenic Role and Therapeutic Perspectives 9
Coexistence of SCN4A and CLCN1 mutations in a family with atypical myotonic features: A clinical and functional study 7
Uptake-Dependent and -Independent Effects of Fibroblasts-Derived Extracellular Vesicles on Bone Marrow Endothelial Cells from Patients with Multiple Myeloma: Therapeutic and Clinical Implications 6
ECM Composition Differentially Regulates Intracellular and Extracellular pH in Normal and Cancer Pancreatic Duct Epithelial Cells 5
Target mutation-driven drug discovery 5
Development of Riluzole Analogs with Improved Use-Dependent Inhibition of Skeletal Muscle Sodium Channels 4
A c.1775C > T Point Mutation of Sodium Channel Alfa Subunit Gene (SCN4A) in a Three-Generation Sardinian Family with Sodium Channel Myotonia 3
Improvement of daratumumab- or elotuzumab-mediated NK cell activity by the bi-specific 4-1BB agonist, DARPin α-FAPx4-1BB: A preclinical study in multiple myeloma 1
Totale 1.977
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.221
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.221
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020336 50 15 21 42 26 22 23 27 31 34 35 10
2020/2021440 34 26 32 48 32 42 47 21 31 64 32 31
2021/2022239 17 15 5 20 4 14 4 11 16 40 42 51
2022/2023356 35 54 33 17 24 52 11 54 46 9 14 7
2023/2024197 8 30 15 21 25 61 3 4 5 8 8 9
2024/202529 29 0 0 0 0 0 0 0 0 0 0 0
Totale 1.977